CN110092775B - 靶向cdk4/6激酶抑制剂的晶型 - Google Patents
靶向cdk4/6激酶抑制剂的晶型 Download PDFInfo
- Publication number
- CN110092775B CN110092775B CN201910077459.4A CN201910077459A CN110092775B CN 110092775 B CN110092775 B CN 110092775B CN 201910077459 A CN201910077459 A CN 201910077459A CN 110092775 B CN110092775 B CN 110092775B
- Authority
- CN
- China
- Prior art keywords
- cancer
- compound
- formula
- crystalline form
- cdk4
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (14)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2018100846634 | 2018-01-29 | ||
CN201810084663 | 2018-01-29 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110092775A CN110092775A (zh) | 2019-08-06 |
CN110092775B true CN110092775B (zh) | 2021-09-10 |
Family
ID=67443775
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910077459.4A Active CN110092775B (zh) | 2018-01-29 | 2019-01-28 | 靶向cdk4/6激酶抑制剂的晶型 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110092775B (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102531772B1 (ko) * | 2018-01-29 | 2023-05-11 | 수안주 바이오파마슈티컬 컴퍼니 리미티드 | Cdk4/6 키나아제 억제제를 타겟팅하는 결정형 |
CN112535686B (zh) * | 2019-09-20 | 2022-06-14 | 山东轩竹医药科技有限公司 | 激酶抑制剂的新用途 |
WO2022143969A1 (zh) * | 2020-12-31 | 2022-07-07 | 轩竹生物科技股份有限公司 | 一种治疗癌症的药物组合物 |
CN114748479B (zh) * | 2021-01-08 | 2023-10-20 | 轩竹生物科技股份有限公司 | 一种预防和/或治疗癌症的药物组合物 |
CN114748480B (zh) * | 2021-01-08 | 2023-10-20 | 轩竹生物科技股份有限公司 | 一种预防和/或治疗癌症的药物组合物 |
CN118119610A (zh) * | 2021-12-13 | 2024-05-31 | 轩竹生物科技股份有限公司 | 一种治疗癌症的药物组合物 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010125004A1 (en) * | 2009-04-29 | 2010-11-04 | Nerviano Medical Sciences S.R.L. | Cdk inhibitor salts |
WO2015101293A1 (zh) * | 2013-12-31 | 2015-07-09 | 山东轩竹医药科技有限公司 | 激酶抑制剂及其用途 |
WO2016169422A1 (zh) * | 2015-04-22 | 2016-10-27 | 江苏恒瑞医药股份有限公司 | 一种周期素依赖性蛋白激酶抑制剂的结晶形式及其制备方法 |
-
2019
- 2019-01-28 CN CN201910077459.4A patent/CN110092775B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010125004A1 (en) * | 2009-04-29 | 2010-11-04 | Nerviano Medical Sciences S.R.L. | Cdk inhibitor salts |
WO2015101293A1 (zh) * | 2013-12-31 | 2015-07-09 | 山东轩竹医药科技有限公司 | 激酶抑制剂及其用途 |
WO2016169422A1 (zh) * | 2015-04-22 | 2016-10-27 | 江苏恒瑞医药股份有限公司 | 一种周期素依赖性蛋白激酶抑制剂的结晶形式及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN110092775A (zh) | 2019-08-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110092775B (zh) | 靶向cdk4/6激酶抑制剂的晶型 | |
JP5719770B2 (ja) | 塩酸イコチニブ、合成物、結晶学的形態、併用薬及びその用途 | |
CN113717157B (zh) | 用作cdk7激酶抑制剂的化合物及其应用 | |
CA2946899C (en) | Naphthofuran compounds and compositions for targeting cancer stem cells | |
CN112010839B (zh) | 靶向丝/苏氨酸激酶抑制剂的晶型 | |
CN111902405B (zh) | 靶向cdk4/6激酶抑制剂的晶型 | |
JP7430656B2 (ja) | Cdk4/6活性阻害化合物の結晶形およびその使用 | |
TWI603968B (zh) | 甲磺酸氟馬替尼晶型及其製備方法和用途 | |
WO2021121146A1 (zh) | 氨基嘧啶类化合物甲磺酸盐的晶型a及其制备方法和应用 | |
JP6659850B2 (ja) | キノリン系化合物の塩、その結晶形、調製方法、組成物及び用途 | |
JP5701387B2 (ja) | ベルバミンのジカルボキシミド誘導体、その調製方法及び使用 | |
TW202027750A (zh) | 治療癌症之套組及其方法 | |
JP2015531355A (ja) | 腫瘍治療のための薬剤組成物及びその適用 | |
CN115246863B (zh) | 一种川芎嗪四价铂类化合物、其制备方法及其用途 | |
TWI529174B (zh) | 埃克替尼的晶型及其應用 | |
CN104119321A (zh) | 二氢吲哚酮衍生物的二马来酸盐及其多晶型物 | |
EA042455B1 (ru) | Кристаллическая форма ингибитора, нацеленного на киназу cdk4/6 | |
CN117956999A (zh) | 杂芳基氧基萘类化合物的用途 | |
KR20230152118A (ko) | 약물 조성물 및 이의 제조 방법 및 용도 | |
EP3008070B9 (en) | Polymorph forms of icotinib maleate and uses thereof | |
CN115716850A (zh) | 芳基磷氧化合物的晶型、制备方法及用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
CB02 | Change of applicant information |
Address after: 570105 Tianyi International Building, 85 Binhai Avenue, Longhua District, Haikou City, Hainan Province, 27th Floor Applicant after: Xuanzhu (Hainan) Pharmaceutical Technology Co.,Ltd. Address before: 570105 Tianyi International Building, 85 Binhai Avenue, Longhua District, Haikou City, Hainan Province, 27th Floor Applicant before: Hainan Xuanzhu Pharma Co.,Ltd. |
|
CB02 | Change of applicant information | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 050000 Beijing Tianjin Hebei Collaborative Innovation Demonstration Park, 769 Taihang street, high tech Zone, Shijiazhuang City, Hebei Province 203c507 Applicant after: Xuanzhu Biotechnology Co.,Ltd. Address before: 050000 Beijing Tianjin Hebei Collaborative Innovation Demonstration Park, 769 Taihang street, high tech Zone, Shijiazhuang City, Hebei Province 203c507 Applicant before: Xuanzhu (Shijiazhuang) Biotechnology Co.,Ltd. Address after: 050000 Beijing Tianjin Hebei Collaborative Innovation Demonstration Park, 769 Taihang street, high tech Zone, Shijiazhuang City, Hebei Province 203c507 Applicant after: Xuanzhu (Shijiazhuang) Biotechnology Co.,Ltd. Address before: 570105 Tianyi International Building, 85 Binhai Avenue, Longhua District, Haikou City, Hainan Province, 27th Floor Applicant before: Xuanzhu (Hainan) Pharmaceutical Technology Co.,Ltd. |
|
CB02 | Change of applicant information | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder |
Address after: 050000 Beijing Tianjin Hebei Collaborative Innovation Demonstration Park 203c507, 769 Taihang street, high tech Zone, Shijiazhuang City, Hebei Province Patentee after: Xuanzhu Biotechnology Co.,Ltd. Address before: 050000 Beijing Tianjin Hebei Collaborative Innovation Demonstration Park 203c507, 769 Taihang street, high tech Zone, Shijiazhuang City, Hebei Province Patentee before: Xuanzhu Biotechnology Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder |